Close

Raymond James Starts Blueprint Medicines (BPMC) at Outperform

May 27, 2016 8:16 AM EDT
Get Alerts BPMC Hot Sheet
Price: $86.82 -4.07%

Rating Summary:
    18 Buy, 4 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 14 | New: 22
Join SI Premium – FREE

Raymond James initiated coverage on Blueprint Medicines (NASDAQ: BPMC) with an Outperform rating and a price target of $23.00.

For an analyst ratings summary and ratings history on Blueprint Medicines click here. For more ratings news on Blueprint Medicines click here.

Shares of Blueprint Medicines closed at $18.09 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Raymond James